SCHEMBL26082178

SCHEMBL26082178

c1ccc(-c2nc(-c3ccc4c(c3)oc3ccccc34)nc(-c3ccc4c(c3)oc3cc(-n5c6ccccc6c6cccnc65)ccc34)n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.37
▸ TSHR P16473 2/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ PTGER4 P35408 1/20 0.35
▸ MAPT P10636 4/20 0.34
▸ KDM4E B2RXH2 3/20 0.34
▸ HPGD P15428 3/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ NPC1 O15118 2/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ LMNA P02545 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ AHR P35869 1/20 0.32
▸ PIK3CA P42336 1/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ ABCG2 Q9UNQ0 2/20 0.31
▸ GRM4 Q14833 1/20 0.31
▸ ECE1 P42892 1/20 0.31
▸ HCRTR1 O43613 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23626876 0.97 ALDH1A1 (0.35) ALDH1A1TSHRCYP2C19PTGER4MAPT
SCHEMBL26082170 0.97 ALDH1A1 (0.38) ALDH1A1TSHRCYP2C19PTGER4MAPT
SCHEMBL26082176 0.97 ALDH1A1 (0.38) ALDH1A1TSHRCYP2C19PTGER4MAPT
SCHEMBL23626749 0.96 ALDH1A1 (0.36) ALDH1A1TSHRCYP2C19PTGER4MAPT
SCHEMBL23627213 0.95 ALDH1A1 (0.37) ALDH1A1TSHRCYP2C19PTGER4MAPT
SCHEMBL23626814 0.95 ALDH1A1 (0.37) ALDH1A1TSHRCYP2C19PTGER4MAPT
SCHEMBL26082200 0.94 ALDH1A1 (0.36) ALDH1A1TSHRCYP2C19PTGER4MAPT
SCHEMBL23626880 0.94 ALDH1A1 (0.36) ALDH1A1TSHRCYP2C19PTGER4MAPT
SCHEMBL23626811 0.94 ALDH1A1 (0.36) ALDH1A1TSHRCYP2C19PTGER4MAPT
SCHEMBL26082171 0.93 ALDH1A1 (0.35) ALDH1A1TSHRCYP2C19PTGER4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11873311-B2 Heterocyclic compound, organic electroluminescent device, and electronic device SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2024-01-16 — — US disclosed
US-11873311-B2 Heterocyclic compound, organic electroluminescent device, and electronic device SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2024-01-16 — — US disclosed
US-20230312604-A1 HETEROCYCLIC COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC DEVICE SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 — — US disclosed
US-20230312604-A1 HETEROCYCLIC COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC DEVICE SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230312604-A1 HETEROCYCLIC COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC DEVICE ODC1, LEF1, PIEZO1 ALDH1A1 137/4885TSHR 3792/4885CYP2C19 29/4885
US-11873311-B2 Heterocyclic compound, organic electroluminescent device, and electronic device ODC1, LEF1, PIEZO1 ALDH1A1 137/4885TSHR 3792/4885CYP2C19 29/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback